211 related articles for article (PubMed ID: 17563389)
1. Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor.
Tansky MF; Pothoulakis C; Leeman SE
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10691-6. PubMed ID: 17563389
[TBL] [Abstract][Full Text] [Related]
2. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
3. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
4. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
5. Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.
Schmidlin F; Dery O; DeFea KO; Slice L; Patierno S; Sternini C; Grady EF; Bunnett NW
J Biol Chem; 2001 Jul; 276(27):25427-37. PubMed ID: 11306580
[TBL] [Abstract][Full Text] [Related]
6. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
Koh YH; Tamizhselvi R; Bhatia M
J Pharmacol Exp Ther; 2010 Mar; 332(3):940-8. PubMed ID: 20007404
[TBL] [Abstract][Full Text] [Related]
8. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
Lai JP; Lai S; Tuluc F; Tansky MF; Kilpatrick LE; Leeman SE; Douglas SD
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12605-10. PubMed ID: 18713853
[TBL] [Abstract][Full Text] [Related]
9. Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.
Marvizon JC; Wang X; Lao LJ; Song B
Br J Pharmacol; 2003 Dec; 140(8):1389-98. PubMed ID: 14623771
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of the truncated ghrelin receptor polypeptide attenuates the constitutive activation of phosphatidylinositol-specific phospholipase C by ghrelin receptors but has no effect on ghrelin-stimulated extracellular signal-regulated kinase 1/2 activity.
Chu KM; Chow KB; Leung PK; Lau PN; Chan CB; Cheng CH; Wise H
Int J Biochem Cell Biol; 2007; 39(4):752-64. PubMed ID: 17169600
[TBL] [Abstract][Full Text] [Related]
11. Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R.
Chakraborty S; Nepiyushchikh Z; Davis MJ; Zawieja DC; Muthuchamy M
Microcirculation; 2011 Jan; 18(1):24-35. PubMed ID: 21166923
[TBL] [Abstract][Full Text] [Related]
12. Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor.
McConalogue K; Déry O; Lovett M; Wong H; Walsh JH; Grady EF; Bunnett NW
J Biol Chem; 1999 Jun; 274(23):16257-68. PubMed ID: 10347182
[TBL] [Abstract][Full Text] [Related]
13. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
14. The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity.
Monastyrskaya K; Hostettler A; Buergi S; Draeger A
J Biol Chem; 2005 Feb; 280(8):7135-46. PubMed ID: 15590676
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
16. Activation of the p38 and p42/p44 mitogen-activated protein kinase families by the histamine H(1) receptor in DDT(1)MF-2 cells.
Robinson AJ; Dickenson JM
Br J Pharmacol; 2001 Aug; 133(8):1378-86. PubMed ID: 11498525
[TBL] [Abstract][Full Text] [Related]
17. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
18. Relationship between neurokinin-1 receptor and substance P in the striatum: light and electron microscopic immunohistochemical study in the rat.
Li JL; Wang D; Kaneko T; Shigemoto R; Nomura S; Mizuno N
J Comp Neurol; 2000 Mar; 418(2):156-63. PubMed ID: 10701441
[TBL] [Abstract][Full Text] [Related]
19. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis.
Lau HY; Bhatia M
J Pathol; 2006 Feb; 208(3):364-71. PubMed ID: 16369913
[TBL] [Abstract][Full Text] [Related]
20. Substance P and Neurokinin 1 receptor - expression is affected in the ileum of mice with mutation in the W locus.
Faussone-Pellegrini MS; Vannucchi MG
J Cell Mol Med; 2006; 10(2):511-8. PubMed ID: 16796816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]